Latest News and Press Releases

LONDON, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In late November 2018, NetScientific (AIM: NSCI) announced that its portfolio company PDS Biotechnology and Edge Therapeutics (NASDAQ: EDGE) will merge. The...

LONDON, Nov. 22, 2018 (GLOBE NEWSWIRE) -- We expect Immutep (IMMP:US) to deliver on a number of important milestones in the year ahead. The AIPAC Phase II study of its APC activator eftilagimod...

LONDON, Nov. 21, 2018 (GLOBE NEWSWIRE) -- InMed recently reported results for the first quarter of FY19 and continues to make solid progress in bringing INM-750 for epidermolysis bullosa (EB) into...

LONDON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Quantum Genomics (ALQGC) released data from the Phase IIb NEW-HOPE trial, which strongly suggests that firibistat is an efficacious, safe drug with a...

LONDON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Auris Medical (EARS) is a clinical-stage biopharmaceutical company developing pharmacotherapies for neurologic disorders of the inner ear. The company’s...

LONDON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- We believe one of the main reasons for the devaluation of Probiodrug’s (PBD) shares over the past year was the largely disappointing industry newsflow...

LONDON, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Kazia (KZIA) has added two further indications to the development program for its brain-penetrant PI3K inhibitor GDC-0084 through collaborations with...

LONDON, Oct. 24, 2018 (GLOBE NEWSWIRE) -- NetScientific (NSCI) announced the completion of a $10m Series A funding for Glycotest with Fosun Pharma, a Chinese pharmaceutical company with a market...

LONDON, Oct. 19, 2018 (GLOBE NEWSWIRE) -- NetScientific (NSCI) recently announced half-year results for 2018, with incremental progress continuing to be made, although we are yet to see that...

LONDON, United Kingdom, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Orège (OREGE) has developed a proprietary technology that reduces sludge treatment costs for clients by up to 80% and implies average...